Formyl peptide receptor agonists as dual action therapeutics for pulmonary hypertension

被引：0
|
作者：
Studley, W. [1 ]
机构：
[1] Monash Univ, Melbourne, Vic, Australia
来源：
RESPIROLOGY | 2023年 / 28卷
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TP 148
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [1] Conformational aspects of human formyl-peptide receptor agonists
    Dalpiaz, A
    Vertuani, G
    Scatturin, A
    Vitali, F
    Varani, K
    Spisani, S
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2003, 53 (11): : 793 - 798
  • [2] Identification of formyl peptide receptor agonists through screening of a compound library
    Forsman, H.
    Kalderen, C.
    Nordin, A.
    Jensen, A. J.
    Dahlgren, C.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 : 38 - 38
  • [3] Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists
    Wurtz, Nicholas R.
    Johnson, James A.
    Viet, Andrew
    Shirude, Pravin S.
    Baligar, Vishweshwaraiah
    Madduri, Sudhakara
    Cheney, Daniel L.
    Park, Hyunsoo
    Lupisella, John A.
    Hsu, Mei-Yin
    Abousleiman, Mojgan
    Galella, Michael A.
    Aulakh, Darpandeep
    Dierks, Elizabeth A.
    Garcia, Ricardo A.
    Ostrowski, Jacek
    Kick, Ellen K.
    Wexler, Ruth R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (06): : 943 - 948
  • [4] Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists
    Dufton, Neil
    Perretti, Mauro
    PHARMACOLOGY & THERAPEUTICS, 2010, 127 (02) : 175 - 188
  • [5] Different receptor coupling and trafficking profiles of structurally distinct formyl peptide receptor 2 agonists
    Peng, Cheng
    Vecchio, Elizabeth A.
    Nguyen, Anht. N.
    De Seram, Mia
    Tang, Ruby
    Woodman, Owen L.
    May, Lauren T.
    Zhao, Peishen
    Ritchie, Rebecca H.
    Qin, Chengxue Helena
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 683 - 685
  • [6] Treating Hypertension With An Anti-inflammatory Formyl Peptide Receptor Agonist
    Jackson, Kristy L.
    Ritchie, Rebecca H.
    Giddy, Thomas
    Deo, Minh
    Woodman, Owen L.
    Head, Geoff
    Qin, Chengxue H.
    HYPERTENSION, 2020, 76
  • [7] Formyl peptide receptor type 2 agonists to kick-start resolution pharmacology
    Perretti, Mauro
    Godson, Catherine
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (20) : 4595 - 4600
  • [8] Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis
    Crocetti, Letizia
    Vergelli, Claudia
    Guerrini, Gabriella
    Giovannoni, Maria Paola
    Kirpotina, Liliya N.
    Khlebnikov, Andrei, I
    Ghelardini, Carla
    Mannelli, Lorenzo Di Cesare
    Lucarini, Elena
    Schepetkin, Igor A.
    Quinn, Mark T.
    MOLECULES, 2021, 26 (21):
  • [9] Is Natriuretic Peptide Receptor C a New Target for Hypertension Therapeutics?
    Qi, YanFei
    Raizada, Mohan K.
    HYPERTENSION, 2014, 63 (04) : 661 - 662
  • [10] Glucagon-like peptide-1 Receptor Agonists reduce the Incidence of Echocardiographic Pulmonary Hypertension
    Garry, Jonah
    Kundu, Suman
    Eden, Svetlana
    Alcorn, Charles
    Freiberg, Matthew
    Brittain, Evan
    CIRCULATION, 2024, 150
12345